Your browser doesn't support javascript.
loading
Are patients with hormonally functional phaeochromocytoma and paraganglioma initially receiving a proper adrenoceptor blockade? A retrospective cohort study.
Luiz, Henrique Vara; Tanchee, Mary Jane; Pavlatou, Maria G; Yu, Run; Nambuba, Joan; Wolf, Katherine; Prodanov, Tamara; Wesley, Robert; Adams, Karen; Fojo, Tito; Pacak, Karel.
Afiliación
  • Luiz HV; Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
  • Tanchee MJ; Department of Endocrinology and Diabetology, Hospital Garcia de Orta, Almada, Portugal.
  • Pavlatou MG; Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
  • Yu R; Section of Endocrinology and Metabolism, University of Santo Tomas Hospital, España, Manila, Philippines.
  • Nambuba J; Clinical Neuroendocrinology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
  • Wolf K; Division of Endocrinology and Carcinoid and Neuroendocrine Tumour Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Prodanov T; Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
  • Wesley R; Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
  • Adams K; Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
  • Fojo T; Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, MD, USA.
  • Pacak K; Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
Clin Endocrinol (Oxf) ; 85(1): 62-9, 2016 07.
Article en En | MEDLINE | ID: mdl-26998836
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Paraganglioma / Feocromocitoma / Guías de Práctica Clínica como Asunto / Neoplasias de las Glándulas Suprarrenales / Antagonistas Adrenérgicos Tipo de estudio: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Clin Endocrinol (Oxf) Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Paraganglioma / Feocromocitoma / Guías de Práctica Clínica como Asunto / Neoplasias de las Glándulas Suprarrenales / Antagonistas Adrenérgicos Tipo de estudio: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Clin Endocrinol (Oxf) Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos